Skip to main content
ViroGates A/S logo

ViroGates A/S — Investor Relations & Filings

Ticker · VIRO ISIN · DK0061030574 LEI · 5493007TX8XS56RMZD94 ST Manufacturing
Open in API
Filings indexed 162 across all filing types
Latest filing 2022-04-18 Regulatory Filings
Country DK Denmark
Listing ST VIRO

About ViroGates A/S

https://www.virogates.com/

ViroGates A/S is an in-vitro diagnostics company that develops and markets blood tests to measure chronic inflammation. The company's core product line, suPARnostic®, is based on the suPAR (soluble urokinase Plasminogen Activator Receptor) biomarker. This biomarker measures the activation level of the immune system to predict patient outcomes, disease risk, and the severity of chronic inflammation. The primary applications for suPARnostic® products are in hospitals for patient triaging, in the longevity market for health assessment, and in clinical research. The technology aims to improve patient care, optimize resource allocation in healthcare settings, and advance inflammation-based diagnostics.

Recent filings

Filing Released Lang Actions
ViroGates announces a current total of 33 clinical routine hospital customers and adjusts its disclosure policy
Regulatory Filings Classification · 95% confidence The document is a company announcement from ViroGates regarding an update on their customer base and a change in their disclosure policy. It is not a full financial report, but rather a corporate update. While it mentions the upcoming Q1 report, it is not the report itself. It fits the definition of a general regulatory announcement or corporate update, which falls under the RNS (Regulatory Filings) category as the fallback for miscellaneous corporate announcements.
2022-04-18 English
ViroGates announces clinical routine use in Portugal
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding a business development update (clinical routine use of a product in Portugal). It does not fit into specific categories like financial reports, dividends, or board changes. As it is a general corporate announcement regarding operational progress, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate news.
2022-04-06 English
ViroGates announces clinical routine use in Portugal
Regulatory Filings Classification · 95% confidence The document is a short company announcement (under 4,000 characters) regarding a business update (clinical routine use of a product in Portugal). It does not fit into specific categories like financial reports, board changes, or shareholder voting. As it is a general corporate announcement that does not fall into the other specialized categories, it is classified as a Regulatory Filing (RNS).
2022-04-06 English
ViroGates issues warrants to key employees
Share Issue/Capital Change Classification · 95% confidence The document is a company announcement regarding the issuance of warrants to key employees as part of a long-term share-based incentive program. It details the terms of the warrants, including vesting periods, exercise prices, and the impact on outstanding shares. This type of corporate action, involving the creation of new potential equity instruments for employees, falls under the category of share issues or capital changes.
2022-03-25 English
ViroGates issues warrants to key employees
Share Issue/Capital Change Classification · 95% confidence The document is a company announcement regarding the issuance of warrants to key employees as part of a long-term share-based incentive program. It details the terms of the warrants, the number of shares involved, and the purpose of the grant. This falls under the category of capital structure changes or share-related incentive programs, which is best classified as 'Share Issue/Capital Change' (SHA) as it involves the potential future issuance of shares and changes to the company's capital structure.
2022-03-25 English
ViroGates announces its Annual Report 2021: Revenue growth of 43% and strong scientific results
Report Publication Announcement Classification · 95% confidence The document is a company announcement from ViroGates regarding the publication of their 2021 Annual Report. It provides a summary of financial highlights and business results but explicitly states that it is a summary to be read in conjunction with the full Annual Report, which is provided as an attachment. Following the 'Menu vs Meal' rule, since this is a short announcement (under 5,000 characters of core content, excluding boilerplate) that directs the reader to the actual report, it is classified as a Report Publication Announcement (RPA).
2022-03-23 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.